Search results for hoxa5

166 hits were found for hoxa5

# Family MCID Name MIFTS Score
1
P BRS047 Breast Cancer 98 24.798
2
EMB004 Embryonal Carcinoma 56 17.459
3
P PLM037 Pulmonary Hypertension 72 16.121
4
c LKM061 Leukemia, Acute Myeloid 83 14.499
5
CLB002 Clubfoot 51 8.729
6
P MYL006 Myeloid Leukemia 61 6.269
7
c SML038 Small Cell Cancer of the Lung 69 5.880
8
P CLR023 Colorectal Cancer 100 4.962
9
P LKM002 Leukemia 67 4.951
10
P LNG032 Lung Cancer 98 4.383
11
OST159 Osteogenic Sarcoma 66 3.920
12
CRV035 Cervical Cancer 73 3.586
13
P GST053 Gastric Cancer 83 3.457
14
P LKM062 Leukemia, Acute Lymphoblastic 69 3.280
15
P HMN010 Hemangioma 62 3.176
16
SQM006 Squamous Cell Carcinoma 60 3.176
17
c ACT073 Acute Leukemia 58 3.100
18
P HPT023 Hepatocellular Carcinoma 96 3.085
19
P RSP003 Respiratory Failure 74 2.975
20
c LKM063 Leukemia, Chronic Myeloid 71 2.940
21
P THR014 Thrombocytopenia 66 2.826
22
c THR001 Thrombocytopenia Due to Platelet Alloimmunization 60 2.826
23
c BDY010 Body Mass Index Quantitative Trait Locus 4 46 2.747
24
c BDY011 Body Mass Index Quantitative Trait Locus 10 45 2.747
25
c BDY005 Body Mass Index Quantitative Trait Locus 9 47 2.747
26
c BDY012 Body Mass Index Quantitative Trait Locus 7 44 2.747
27
P BDY004 Body Mass Index Quantitative Trait Locus 11 83 2.747
28
c BDY006 Body Mass Index Quantitative Trait Locus 8 44 2.747
29
c BDY017 Body Mass Index Quantitative Trait Locus 14 45 2.747
30
c BDY020 Body Mass Index Quantitative Trait Locus 19 52 2.747
31
c BDY015 Body Mass Index Quantitative Trait Locus 12 46 2.747
32
c BDY019 Body Mass Index Quantitative Trait Locus 18 47 2.747
33
P LNG064 Lung Cancer Susceptibility 3 70 2.747
34
DWR001 Dwarfism 44 2.672
35
HYP457 Hypertrophic Scars 42 2.580
36
TCL028 T-Cell Lymphoblastic Leukemia/lymphoma 46 2.580
37
c LKM005 Leukemia, T-Cell, Chronic 34 2.580
38
P OVR042 Ovarian Cancer 88 2.491
39
DDF001 Dedifferentiated Liposarcoma 49 2.397
40
THY006 Thymus Lymphoma 27 2.397
41
P LPS002 Liposarcoma 64 2.397
42
c WLM013 Wilms Tumor 1 66 2.298
43
c CHR085 Chronic Cervicitis 32 2.298
44
CRV038 Cervical Squamous Cell Carcinoma 58 2.298
45
P CRV039 Cervicitis 52 2.298
46
P BNC003 Bone Cancer 58 2.298
47
PRM243 Primary Bone Cancer 22 2.298
48
AGN016 Aging 54 2.192
49
P SPP010 Suppressor of Tumorigenicity 3 51 2.192
50
GLB002 Glioblastoma 67 2.192
51
END007 Endosalpingiosis 37 2.192
52
P OVR046 Ovarian Cyst 46 2.192
53
P PRC019 Precocious Puberty 47 2.192
54
RNL114 Renal Cell Carcinoma, Nonpapillary 80 2.079
55
BRN027 Brain Angioma 22 2.079
56
HMN016 Hemangioendothelioma 34 2.079
57
AND002 Androgen Insensitivity Syndrome 63 1.955
58
ANN002 Anencephaly 57 1.955
59
CMP034 Complete Androgen Insensitivity Syndrome 55 1.955
60
NRL016 Neural Tube Defects 81 1.955
61
ORL015 Oral Squamous Cell Carcinoma 43 1.955
62
CLR030 Clear Cell Renal Cell Carcinoma 54 1.955
63
END057 Endometrial Cancer 72 1.734
64
PRC049 Precursor T-Cell Acute Lymphoblastic Leukemia 45 1.664
65
P MLT020 Multiple Sclerosis 79 1.664
66
P HYP086 Hypothyroidism 69 1.664
67
P PNC035 Pancreatic Cancer 86 1.534
68
PLY150 Polykaryocytosis Inducer 29 1.480
69
P MSC003 Muscular Atrophy 52 1.416
70
P SPN046 Spinal Muscular Atrophy 63 1.416
71
ATH013 Atherosclerosis Susceptibility 63 1.293
72
LPD008 Lipid Metabolism Disorder 62 1.293
73
MYL009 Myelodysplastic Syndrome 67 1.241
74
VTR016 Vater/vacterl Association 49 1.156
75
P PSR002 Psoriasis 63 1.156
76
PST011 Pustulosis of Palm and Sole 52 1.156
77
CHL061 Childhood Leukemia 47 1.156
78
P ADN016 Adenocarcinoma 63 1.156
79
ESP020 Esophageal Atresia 60 1.156
80
VCT001 Vacterl Association 47 1.156
81
P THL005 Thalassemia 56 1.001
82
ART140 Arteries, Anomalies of 53 1.001
83
c BTT014 Beta-Thalassemia 72 1.001
84
LPP008 Lipoprotein Quantitative Trait Locus 65 1.001
85
P LYM118 Lymphoma 67 1.001
86
c DPH024 Diaphragmatic Hernia, Congenital 64 1.001
87
P MDL005 Medulloblastoma 75 1.001
88
PLM129 Pulmonary Disease, Chronic Obstructive 74 1.001
89
P OST002 Osteoporosis 76 0.818
90
c BNM022 Bone Mineral Density Quantitative Trait Locus 8 45 0.818
91
P BNM029 Bone Mineral Density Quantitative Trait Locus 15 48 0.818
92
CHL065 Cholangiocarcinoma 58 0.818
93
OVR012 Ovarian Serous Cystadenocarcinoma 55 0.818
94
GLL048 Glial Tumor 52 0.818
95
P VSC007 Vascular Disease 63 0.818
96
CYS014 Cystadenocarcinoma 51 0.818
97
KRT002 Keratomalacia 55 0.818
98
INT079 Intrahepatic Cholangiocarcinoma 51 0.818
99
SRS001 Serous Cystadenocarcinoma 52 0.818
100
PNC041 Pancreatic Ductal Adenocarcinoma 51 0.818
101
GLM045 Glioma 63 0.818
102
P MLN008 Melanoma 76 0.663
103
LYM133 Lymphoma, Hodgkin, Classic 74 0.578
104
CLP005 Ciliopathy 41 0.578
105
PRM163 Primary Mediastinal Large B-Cell Lymphoma 40 0.578
106
ACT248 Acute Monoblastic/monocytic Leukemia 26 0.578
107
P BLD134 Bladder Cancer 79 0.578
108
c SPS128 Spastic Paraplegia 7, Autosomal Recessive 58 0.578
109
PLM134 Pulmonary Fibrosis, Idiopathic 76 0.578
110
P AST005 Asthma 76 0.578
111
c AMY091 Amyotrophic Lateral Sclerosis 1 88 0.578
112
P ANT080 Antigen Defined by Monoclonal Antibody Aj9 18 0.578
113
AGN018 Agenesis of Corpus Callosum, Cardiac, Ocular, and Genital Syndrome 57 0.578
114
P ANP001 Anaplastic Large Cell Lymphoma 61 0.578
115
PRP036 Peripheral T-Cell Lymphoma 53 0.578
116
DFF005 Diffuse Large B-Cell Lymphoma 54 0.578
117
P CRB045 Cerebellar Hypoplasia 40 0.578
118
CHL152 Childhood Acute Lymphocytic Leukemia 50 0.578
119
c RTN041 Retinitis Pigmentosa 11 42 0.578
120
HND004 Hand-Foot-Genital Syndrome 47 0.578
121
LYM143 Lymphoma, Non-Hodgkin, Familial 75 0.578
122
P RTN024 Retinoblastoma 73 0.578
123
c TYP009 Type 2 Diabetes Mellitus 92 0.578
124
P KBK002 Kabuki Syndrome 1 65 0.578
125
ESP021 Esophageal Cancer 83 0.578
126
DCT002 Ductal Carcinoma in Situ 58 0.578
127
ANP032 Anaplastic Pleomorphic Xanthoastrocytoma 16 0.578
128
RPD005 Rapidly Involuting Congenital Hemangioma 46 0.578
129
P BCL017 B-Cell Lymphoma 59 0.578
130
P SPN042 Spinal Cord Ependymoma 29 0.578
131
ALL006 Allergic Asthma 56 0.578
132
MDS006 Mediastinal Gray Zone Lymphoma 21 0.578
133
CLL010 Cellular Ependymoma 57 0.578
134
GRY001 Gray Zone Lymphoma 34 0.578
135
P ALK015 Alk-Positive Anaplastic Large Cell Lymphoma 39 0.578
136
CRV025 Cervical Incompetence 35 0.578
137
BCR002 Bicornuate Uterus 24 0.578
138
TRT001 Teratocarcinoma 42 0.578
139
P PLM036 Pulmonary Fibrosis 66 0.578
140
OST012 Osteoarthritis 77 0.578
141
LNG099 Lung Disease 62 0.578
142
P BNG030 Benign Ependymoma 51 0.578
143
PLM020 Pleomorphic Xanthoastrocytoma 40 0.578
144
P LTR001 Lateral Sclerosis 58 0.578
145
KRT009 Keratosis 53 0.578
146
P HYP040 Hypospadias 51 0.578
147
TCL027 T-Cell Acute Lymphoblastic Leukemia 51 0.578
148
P MTR014 Motor Neuron Disease 65 0.578
149
P INS002 in Situ Carcinoma 53 0.578
150
ACT114 Acute Myeloblastic Leukemia Without Maturation 26 0.578
151
TCL008 T-Cell Lymphoma 1a 17 0.578
152
OVR094 Ovarian Epithelial Cancer 39 0.578
153
TRC035 Tracheal Agenesis 30 0.533
154
c NRB010 Neuroblastoma 1 59 0.470
155
IRN008 Iron Overload in Africa 51 0.420
156
c CHL136 Cholestasis, Progressive Familial Intrahepatic, 2 57 0.420
157
HPT079 Hepatoid Adenocarcinoma 39 0.420
158
NNL005 Non-Alcoholic Fatty Liver Disease 63 0.420
159
RJS001 Ruijs-Aalfs Syndrome 47 0.420
160
c HPT073 Hepatitis C Virus 71 0.420
161
PDT042 Pediatric Hepatocellular Carcinoma 49 0.420
162
c PRG047 Progressive Familial Intrahepatic Cholestasis 64 0.420
163
ADL096 Adult Hepatocellular Carcinoma 60 0.420
164
FBR086 Fibrolamellar Carcinoma 59 0.420
165
HPT011 Hepatocellular Clear Cell Carcinoma 46 0.420
166
PTY007 Pityriasis Rotunda 26 0.420
Content
Loading form....